|
|
||||||||
Center for Perinatal Biology, Department of Pharmacology, Loma Linda University School of Medicine, Loma Linda, California 92350
| |
ABSTRACT |
|---|
|
|
|---|
The effect of chronic hypoxia on free
intracellular Ca2+ concentration
([Ca2+]i)
and Ca2+ sensitivity of
myofilaments during agonist stimulation was examined in uterine
arteries obtained from normoxic and chronically hypoxic pregnant sheep
maintained at high altitude (3,820 m) for ~110 days. Smooth muscle
[Ca2+]i
was measured simultaneously with muscle contraction in the same intact
tissue. Whereas both KCl and 5-HT increased
[Ca2+]i
and tension simultaneously in the uterine artery, 5-HT produced significantly greater contractile tension (in g) than KCl at a given
amount of
[Ca2+]i
as indicated by the ratio of fura 2 fluorescence intensity induced by
excitation at 340 nm to that induced at 380 nm (29.8 ± 6.9 vs. 16.9 ± 4.0, P < 0.05).
Chronic hypoxia did not change KCl-induced contractions, nor did it
affect KCl-mediated increases in
[Ca2+]i.
In contrast, chronic hypoxia significantly inhibited 5-HT-induced contractions and decreased the 5-HT-stimulated increase in
[Ca2+]i
(pD2 7.46 ± 0.18
6.86 ± 0.11, P < 0.05, where
pD2 is
log half-maximal
effective concentration) in uterine arteries. In addition, the slope (g
tension/nM
[Ca2+]i)
of the 5-HT-mediated
[Ca2+]i-tension
relationship was significantly decreased in chronically hypoxic
arteries (0.024 ± 0.002
0.013 ± 0.001, P < 0.01). The results suggest that
chronic hypoxia suppresses agonist-mediated Ca2+ homeostasis in uterine
arteries by inhibiting Ca2+
mobilization and the agonist-enhanced
Ca2+ sensitivity of myofilaments.
uterine contractions; 5-hydroxytryptamine
| |
INTRODUCTION |
|---|
|
|
|---|
CHRONIC HYPOXIA has been known for years to have profound effects on vascular contractility in a variety of vascular beds and to produce a sustained attenuation of uterine, cerebral, pulmonary, and systemic vasoreactivity in response to a variety of agonists such as serotonin [5-hydroxytryptamine (5-HT)], norepinephrine, phenylephrine, angiotensin II, and arginine vasopressin (7, 12, 13, 29, 30). Yet the cellular and biochemical mechanisms underlying chronic hypoxia-mediated vascular responses are not well understood. Previous studies from this laboratory have suggested that chronic hypoxia suppresses vascular smooth muscle pharmacomechanical coupling by altering the function of cell membrane receptors as well as the postreceptor mechanisms (12, 13, 29). The finding that chronic hypoxia significantly decreased 5-HT-induced D-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] synthesis (13) suggests that chronic hypoxia may suppress agonist-mediated Ca2+ mobilization in vascular smooth muscle.
Not only does free intracellular Ca2+ concentration ([Ca2+]i) play an important role in determining contractions of vascular smooth muscle, but also Ca2+ sensitivity of smooth muscle myofilaments provides a key determinant of contractile force (15, 16, 28). It has been well documented that, compared with K+ stimulation, agonists produce greater contractions at a given Ca2+ concentration in smooth muscle (6, 16, 27). This agonist-enhanced Ca2+ sensitivity of contractile proteins can be subject to physiological and/or pathophysiological modulations. For example, in sheep cerebral arteries, 5-HT-enhanced Ca2+ sensitivity was GTP dependent and was physiologically modulated (2). Our recent finding that for a given amount of Ins(1,4,5)P3 synthesis induced by 5-HT less contraction was produced in the uterine artery from chronically hypoxic animals than that from control ones (13) lets us hypothesize that chronic hypoxia inhibits Ca2+ sensitivity of myofilaments in the uterine artery. To our knowledge, no studies have yet been performed to directly examine the effect of chronic hypoxia on the regulation of Ca2+ homeostasis and Ca2+ sensitivity in vascular smooth muscle. Thus the object of this investigation was to study further the effect of chronic hypoxia on intracellular Ca2+ mobilization and Ca2+ sensitivity of myofilaments in the uterine artery. To avoid permeabilization of smooth muscle cells, we have adopted a method to measure [Ca2+]i and muscle contraction simultaneously in intact vascular smooth muscle.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Tissue preparation. Uterine arteries were obtained from normoxic and chronically hypoxic pregnant sheep as reported previously (12, 13). Briefly, time-dated pregnant sheep were obtained from Nebeker Ranch (Lancaster, CA; altitude ~300 m) with arterial PO2 (PaO2) of 102 ± 2 mmHg. Uterine arteries were obtained from near-term pregnant sheep (~140 days gestation). To induce chronic hypoxia, we transported the animals at 30 days gestation to Barcroft Laboratory, White Mountain Research Station (Bishop, CA; altitude 3,820 m; PaO2 60 ± 2 mmHg), and kept them there for ~110 days, whereas the control animals were maintained near sea level (~300 m) throughout the gestation period. The animals were transported to our laboratory immediately before the studies. The maternal arterial blood gas values were measured immediately before and after transportation of sheep to the laboratory, and blood samples (0.5 ml) taken from the femoral artery with a chronic catheter were measured with a blood gas analyzer (ABL300 Radiometer, Copenhagen, Denmark, at 39°C) (13). Anesthesia of the animals was rapidly induced with intravenous injection of thiamylal (10 mg/kg). The ewes were then intubated, and anesthesia was maintained on 1.5-2.0% halothane in oxygen throughout surgery. An incision was made in the abdomen and the uterus was exposed. The fourth branches of the main uterine arteries were isolated without stretching and were placed into a modified Krebs solution (pH 7.4) of the following composition (in mM): 115.21 NaCl, 4.70 KCl, 1.80 CaCl2, 1.16 MgSO4, 1.18 KH2PO4, 22.14 NaHCO3, and 7.88 dextrose. EDTA (0.03 mM) was added to suppress oxidation of amines. The Krebs solution was oxygenated with a mixture of 95% oxygen-5% carbon dioxide. After removal of the tissues, animals were killed with T-61 (euthanasia solution, Hoechst-Roussel, Somerville, NJ).
The arteries were carefully cleaned of surrounding connective tissue and cut into rings of ~1 mm in length. To exclude the influence of the endothelium, we removed endothelial cells by gentle rotation of the artery rings on an approximately sized, rough-surfaced blunt hypodermic needle as described previously (13). Validation of endothelium removal was demonstrated by the elimination of endothelium-dependent relaxation induced by ATP and by the examination of endothelial integrity using en-face silver staining. All procedures and protocols used in the present studies were approved by the Animal Research Committee of Loma Linda University and followed the guidelines put forward in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.Simultaneous measurement of [Ca2+]i and contraction. Smooth muscle [Ca2+]i was measured simultaneously with muscle contraction as reported by Sato et al. (27). The arterial ring was attached to an isometric force transducer in a 5-ml tissue bath mounted on a CAF-110 intracellular Ca2+ analyzer (Jasco, Tokyo, Japan). The tissue was equilibrated in Krebs buffer under a resting tension of 0.5 g for 40 min. After two stimulations of the tissue with 120 mM KCl, tissue autofluorescence intensity was measured at 510 nm induced by 340- and 380-nm excitations, respectively. The ring was then loaded with 5 µM fura 2-acetoxymethyl ester (fura 2-AM) for 4 h in the presence of 0.02% Cremophor EL at room temperature (25°C). After loading, the tissue was washed with Krebs solution at 37°C for 30 min to allow for hydrolysis of fura 2 ester groups by endogenous esterase.
Contractile tension and fura 2 fluorescence were measured simultaneously at 37°C in the same tissue. Isometric tensions were measured. Concentration-response curves were obtained by cumulative additions of the agonist in increments of approximately one-half log unit of concentration. During the stimulation with an agonist, the tissue was illuminated alternatively (125 Hz) at excitation wavelengths of 340 and 380 nm, respectively, by means of two monochromators in the light path of a 75-W Xe lamp. Fluorescence emission from the tissue was measured at 510 nm by a photomultiplier. The fluorescence intensity at each excitation wavelength (F340 and F380, respectively) and the ratio of these two fluorescence values (R340/380) were recorded with a time constant of 250 ms and stored with the force signal on a computer. At the end of experiments, the maximum fluorescence ratio was determined in a phosphate-free, bicarbonate-free 120 mM K+-5 mM Ca2+ salt solution containing 10 µM ionomycin and 100 µM 5-HT. The minimum fluorescence ratio was determined by adding 10 mM ethylene glycol-bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic
acid (EGTA). [Ca2+]i
was determined, as described by Grynkiewictz et al. (11), using
the formula
[Ca2+]i
(nM) = Kd × [(R
Rmin)/(Rmax
R)] × (Sf2/Sb2),
where Kd (224 nM
at 37°C) is the dissociation constant of fura 2 for
Ca2+; R is the ratio of
fluorescence of the sample at 340 to that at 380 nm;
Rmin and
Rmax represent the ratios of
fluorescence at the same wavelengths in the presence of zero and
saturating Ca2+, respectively; and
Sf2/Sb2
is the ratio of fluorescence of fura 2 at 380 nm in zero
Ca2+ to that in saturating
Ca2+, respectively.
Materials. Fura 2-AM was obtained from Molecular Probes (Eugene, OR). 5-HT was purchased from Research Biomedicals (Natick, MA). Ionomycin, EGTA, Cremophor EL, KCl, and other chemicals were from Sigma (St. Louis, MO).
Data analysis.
Concentration-response curves were analyzed by computer-assisted
nonlinear regression to fit the data using GraphPad Prism (GraphPad
Software, San Diego, CA). Half-maximal effective concentration (EC50) values for
an agonist in each experiment were taken as the molar concentration at
which the contraction-response curve intersected 50% of the maximum
response and were expressed as pD2
(
log EC50) values.
Comparison of regression lines was performed using GraphPad Prism
(GraphPad Software). Results were expressed as means ± SE, and the
differences were evaluated for statistical significance
(P < 0.05) by analysis of variance.
| |
RESULTS |
|---|
|
|
|---|
In the arterial rings loaded with fura 2, an increase in [Ca2+]i resulted in an increase in F340, a decrease in F380, and an increase in R340/380. Typical traces of simultaneous measurement of 5-HT-stimulated increases in [Ca2+]i and muscle tension development in the uterine artery smooth muscle are shown in Fig. 1. The time delay between the increase in the fluorescence ratio and the contractile force development due to 5-HT stimulation was 2.7 ± 0.33 s (n = 10), which was longer than that due to KCl stimulation (1.1 ± 0.01 s, n = 10).
|
As shown in Fig. 2, addition of 120 mM KCl or 10 µM 5-HT increased both R340/380 and muscle tension in the uterine artery. The rate of increase in the fluorescence due to 5-HT was slightly slower than that due to high KCl. For both KCl- and 5-HT-induced responses, washing of the tissues with normal Krebs solution decreased R340/380, which was followed by muscle relaxation. Figure 2 also depicts that, in the same tissue, although the 10 µM 5-HT-induced increment in [Ca2+]i was similar to that induced by 120 mM KCl, the contractile tension mediated by 5-HT was significantly greater than that by KCl. As shown in Fig. 3, contractile tension of the uterine artery at a given amount of increase in [Ca2+]i mediated by KCl and 5-HT was 16.9 ± 4.0 and 29.8 ± 6.9 (g/R340/380), respectively (P < 0.05, n = 4).
|
|
Cumulative additions of KCl induced concentration-dependent increases in contraction of the uterine arteries from both normoxic and chronically hypoxic animals with pD2 values of 1.73 ± 0.05 and 1.68 ± 0.07, respectively (P > 0.05, n = 5) and maximum contractions of 3.19 ± 0.35 and 2.86 ± 0.37 g, respectively (P > 0.05) (Fig. 4). In accordance with the contractile responses, chronic hypoxia showed no effect on KCl-mediated concentration-dependent increases in [Ca2+]i in uterine arteries (Fig. 5). The pD2 values were 1.74 ± 0.03 for normoxic arteries and 1.71 ± 0.16 for chronically hypoxic ones (P > 0.05, n = 5).
|
|
The [Ca2+]i-tension relationships depicted from the data of simultaneous measurement of [Ca2+]i and tension in the same tissue (see MATERIALS AND METHODS) indicated that there was a positive correlation between these two parameters in the presence of cumulative doses of KCl in the uterine arteries from both normoxic and chronically hypoxic animals (Fig. 6). The slopes (g tension/nM [Ca2+]i) of the lines were the same in the normoxic arteries (0.015 ± 0.003) and chronically hypoxic ones (0.015 ± 0.002) (P > 0.05, n = 5).
|
In contrast to KCl-induced responses, chronic hypoxia significantly decreased contractile sensitivity of the uterine arteries in response to 5-HT (Fig. 7). The pD2 values of 5-HT-mediated concentration-dependent contractions were 7.20 ± 0.10 and 6.63 ± 0.13 for normoxic and chronically hypoxic arteries, respectively (P < 0.05, n = 6). The maximum contractile responses were 5.03 ± 0.19 g for normoxic arteries and 3.89 ± 0.14 g for chronically hypoxic arteries (P < 0.05).
|
In agreement with contractile studies, chronic hypoxia also inhibited the potency of 5-HT in stimulating increases in [Ca2+]i in the uterine arteries (Fig. 8). The pD2 value of 5-HT-induced increases in [Ca2+]i was decreased from 7.46 ± 0.18 in normoxic arteries to 6.86 ± 0.11 in chronically hypoxic arteries (P < 0.05, n = 5), although the maximum responses were slightly higher in chronically hypoxic arteries (416.1 ± 11.8 nM) than that in normoxic ones (320.9 ± 12.7 nM) (P > 0.05).
|
Figure 9 shows a positive correlation between muscle tension and [Ca2+]i increased by the cumulative additions of 5-HT in both normoxic and chronically hypoxic arteries. Whereas the slope (g tension/nM [Ca2+]i) of the [Ca2+]i-tension relationship mediated by 5-HT in normoxic arteries (0.024 ± 0.002) was significantly greater than that mediated by KCl (0.015 ± 0.003) (P < 0.05), it significantly decreased in chronically hypoxic arteries (0.013 ± 0.001) (P < 0.01, n = 6). There was no significant difference between the slopes of the [Ca2+]i-tension relationship determined from cumulative additions of KCl (0.015 ± 0.002) and 5-HT (0.013 ± 0.001) in chronically hypoxic arteries (P > 0.05).
|
| |
DISCUSSION |
|---|
|
|
|---|
The major finding of this study is that chronic hypoxia does not affect the electromechanical coupling elicited by KCl but significantly suppresses pharmacomechanical coupling mediated by the activation of GTP-binding protein-coupled receptors in smooth muscle of the uterine artery. The two major components of pharmacomechanical coupling of vascular smooth muscle, Ca2+ mobilization and Ca2+ sensitivity of myofilaments, were significantly suppressed in response to chronic hypoxia.
The relationship of Ca2+ and tension development in vascular smooth muscle can be studied in intact or permeabilized preparations, where [Ca2+]i is either measured or controlled, respectively. Although permeabilization of cell membrane has been commonly used in a variety of smooth muscle preparations (1-3, 18, 19), potential regulatory elements in the cell may be lost during permeabilization (15). In the present study, we were able to measure changes in [Ca2+]i simultaneously with tension in isolated intact uterine artery rings. The correlation of [Ca2+]i and tension obtained for both KCl and 5-HT stimulation is a predictable confirmation of the obligatory role that Ca2+ plays in vascular smooth muscle contraction and is in good agreement with earlier findings (16, 27). The simultaneous measurement of [Ca2+]i with tension in the same intact tissue allowed us to determine directly the precise relationship between [Ca2+]i and tension in the uterine artery and thus to estimate Ca2+ sensitivity of myofilaments with unimpaired excitation-contraction coupling processes and retained regulatory targets for second messenger pathways. The finding of the delay between the agonist-mediated increase in [Ca2+]i and tension development indicates one major component of the common long delay between agonist-receptor interaction and contraction in the smooth muscle and is likely due to prephosphorylation reactions, such as Ca2+-calmodulin diffusion and/or activation of myosin light-chain kinase (MLCK) and, to a lesser extent, the time course of myosin phosphorylation (28).
In most smooth muscles, high-KCl-mediated contractions are completely dependent on extracellular Ca2+, and L-type Ca2+ channel blockers inhibit contraction. In the present study, high KCl induced a sustained increase in [Ca2+]i followed by a sustained contraction in the uterine artery. Simultaneous measurement of [Ca2+]i and tension induced by cumulative addition of KCl indicated a one-to-one ratio in the increments of [Ca2+]i and tension. Furthermore, addition of the L-type Ca2+ channel blocker verapamil (10 µM) completely inhibited the high-KCl-stimulated increases in [Ca2+]i and muscle tension (data not shown). Similar results were obtained in other smooth muscle preparations (16, 27). These data suggest that high KCl contracts smooth muscle of the uterine artery, like most other smooth muscles, through electromechanical coupling and primarily by increasing Ca2+ influx through L-type Ca2+ channels. The finding that the KCl-induced Ca2+ mobilization and [Ca2+]i-tension relationship were the same in the normoxic and chronically hypoxic arteries in the present study suggests that mild chronic hypoxia does not affect the L-type Ca2+ channel in the uterine artery. Studies in rabbit systemic arteries also indicated that KCl-evoked contractions were not affected by moderate hypoxia and that receptor-operated rather than voltage-operated processes were particularly vulnerable to hypoxia (22). However, the finding that KCl-mediated electromechanical coupling was not changed by chronic hypoxia in the present study does not necessarily preclude the possible changes in membrane potential of vascular smooth muscle in response to chronic hypoxia. In fact, many studies suggest that acute hypoxia activates ATP-dependent K+ (K+ATP) channels and relaxes smooth muscle (14, 23, 25). Although studies of the effect of chronic hypoxia on K+ channels and smooth muscle membrane potential are extremely limited, one recent study in conscious instrumented rats suggests that opening of K+ATP channels is not involved in the attenuated vasoreactivity associated with chronic hypoxia (9).
In contrast to KCl-mediated responses, the 5-HT-induced Ca2+ mobilization and [Ca2+]i-tension relationship in the uterine artery were significantly altered by chronic hypoxia. Chronic hypoxia also significantly suppressed the norepinephrine-mediated Ca2+ mobilization and [Ca2+]i-tension relationship in the uterine artery (31). It is unclear whether chronic hypocapnia may also contribute to the changes in responses of the uterine artery observed in the present study. Although arterial PCO2 moderately decreased from 35 to 29 mmHg, the blood pH was not altered (from 7.44 to 7.46).
There are two major components in G protein-coupled receptor-mediated pharmacomechanical coupling: 1) the agonist-induced increase in [Ca2+]i by either release of Ca2+ from intracellular stores or by Ca2+ influx, and 2) the agonist-induced increase in Ca2+ sensitivity of myofilaments. In light of the findings that 5-HT stimulated a rapid increase in Ins(1,4,5)P3 (34, 36) as well as Ca2+ influx through a voltage-independent Ca2+ channel (35) in the uterine artery, the 5-HT-induced increase in [Ca2+]i in the present study is likely due to the combined Ca2+ release from internal stores and the influx of extracellular Ca2+. It has been firmly established that Ins(1,4,5)P3 releases Ca2+ from intracellular stores in a wide variety of cells and tissues, including smooth muscle (4, 8, 28). Although it has been suggested that Ins(1,4,5)P3 plays an important role in agonist-mediated, voltage-insensitive entry of external Ca2+ (5, 32), it is not clear at the present time that such a mechanism operates during 5-HT-induced contraction in the uterine artery. In our recent studies, we have found that chronic hypoxia significantly suppresses the coupling efficiency between activation of 5-HT2 receptors and Ins(1,4,5)P3 synthesis, leading to a decrease in intracellular Ins(1,4,5)P3 levels in the uterine artery (13). Although the decreased Ins(1,4,5)P3 synthesis will certainly lead to a decrease in [Ca2+]i, mechanisms downstream, such as Ins(1,4,5)P3-receptor affinity and density, may also contribute to chronic hypoxia-mediated suppression in 5-HT-induced Ca2+ mobilization in the uterine artery. On its formation, Ins(1,4,5)P3 diffuses into cytosol, where it binds to the Ins(1,4,5)P3 receptors located on the sarcoplasmic reticulum and/or sarcolemma membrane and mediates Ca2+ release (5, 32, 33). The finding that chronic hypoxia inhibited contractile sensitivity of the uterine artery to Ins(1,4,5)P3, i.e., for a given amount of Ins(1,4,5)P3 synthesized less contraction was produced in the chronically hypoxic arteries (13), suggests that the chronic hypoxia-mediated decrease in 5-HT-induced Ca2+ mobilization in the uterine artery may be due in part to changes in the Ins(1,4,5)P3 receptor. Indeed, depending on vascular beds, either Ins(1,4,5)P3 binding affinity to the Ins(1,4,5)P3 receptor or the density of the receptor could be altered by chronic hypoxia. We have found that chronic hypoxia significantly decreases Ins(1,4,5)P3 binding affinity to the Ins(1,4,5)P3 receptor without affecting Ins(1,4,5)P3 receptor numbers in the uterine artery (31). In contrast, chronic hypoxia significantly decreased Ins(1,4,5)P3-receptor density without changing Ins(1,4,5)P3 binding affinity in cerebral arteries (38). Although it was not examined in the present study, the potential effect of chronic hypoxia on the Ca2+ channels responsible for agonist-stimulated influx of Ca2+ into cells is a promising area for future investigation.
Modulation of myosin phosphorylation independent of changes in [Ca2+]i is another major component of pharmacomechanical coupling. In the present study, when [Ca2+]i and tension were measured simultaneously in the same arterial ring, 5-HT always produced greater contraction than KCl for a given increment in [Ca2+]i. The result suggests that 5-HT-mediated modulation of the Ca2+ sensitivity of the contractile apparatus is also a key mechanism governing contractility of the uterine artery. A similar finding of agonist-induced increase in Ca2+ sensitivity of myofilaments has also been demonstrated in other smooth muscle preparations (6, 16, 27). Although it is clear that Ca2+ sensitivity of myofilaments of vascular smooth muscle is primarily determined by the relative activities of MLCK and myosin light-chain phosphatase (MLCP) (15), many studies suggested that agonist-mediated sensitization of myofilaments to Ca2+ was due to inhibition of MLCP, most likely through a GTP-binding protein-dependent pathway (10, 19). We have recently demonstrated that in rabbit and sheep cerebral arteries 5-HT enhances Ca2+ sensitivity of myofilaments through GTP-dependent mechanisms (1-3). Both trimeric (28) and monomeric (17) GTP-binding proteins are proposed to be involved in the enhancement of Ca2+ sensitivity of myofilaments.
In the present study, chronic hypoxia significantly inhibited 5-HT-enhanced Ca2+ sensitivity in the uterine artery. The finding that chronic hypoxia did not affect the KCl-mediated [Ca2+]i-tension relationship but suppressed the slope of the 5-HT-mediated [Ca2+]i-tension relationship suggests that chronic hypoxia specifically inhibits signal transduction processes of GTP-binding protein-coupled receptors. However, the precise cellular and molecular mechanisms underlying the chronic hypoxia-mediated decrease in Ca2+ sensitivity of smooth muscle remain uncertain. One of the second messengers that is thought to play an important role in the inhibition of MLCP is protein kinase C (15, 28). Activation of plasma membrane-associated phosphoinositide-specific phospholipase C stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate and generates Ins(1,4,5)P3 and diacylglycerol, which, in turn, activates protein kinase C. Because chronic hypoxia suppresses this pathway (13), it is likely to decrease protein kinase C activity, leading to an increase in MLCP activity.
Alternatively, the decrease in the agonist-enhanced Ca2+ sensitivity in response to chronic hypoxia may be due to GTP-binding protein-independent mechanisms. We have found that chronic hypoxia significantly increases intracellular guanosine 3',5'-cyclic monophosphate (cGMP) levels in the uterine artery (37), which is likely due to the chronic hypoxia-induced increase in endothelial nitric oxide release, as shown in other studies (20, 26). In light of the finding that cGMP has a profound effect on Ca2+ mobilization in vascular smooth muscle (21), we have shown that 8-bromoguanosine 3',5'-cyclic monophosphate (8-BrcGMP), a membrane-permeable analog of cGMP, decreases agonist-induced Ins(1,4,5)P3 synthesis and Ins(1,4,5)P3 binding affinity to the Ins(1,4,5)P3 receptor in the uterine artery (37). Not only does cGMP regulate Ca2+ mobilization, but also it inhibits Ca2+ sensitivity of myofilaments in vascular smooth muscle. In permeabilized vascular smooth muscle, addition of cGMP-preactivated, cGMP-dependent protein kinase reduced myosin phosphorylation and contractile tension proportionally despite a constant [Ca2+]i, suggesting that cGMP decreased the Ca2+ sensitivity of contractile proteins (24). We also found that in the uterine artery, when [Ca2+]i and contractile tension were measured simultaneously, addition of 8-BrcGMP completely relaxed 5-HT-induced contraction but inhibited only 50% of increased [Ca2+]i (unpublished observation). Although it may be unlikely that elevated cGMP was responsible for the decreases in 5-HT-induced Ca2+ mobilization and Ca2+ myofilament sensitivity in uterine arteries in the present study because the study has been done on endothelium-denuded arteries, potential sustained effects of cGMP that were not immediately reversible on removal of the endothelium should not be precluded.
In conclusion, the present study provides, for the first time, the evidence that mild chronic hypoxia produces, among other effects, a direct effect on vascular smooth muscle of the uterine artery and impairs pharmacomechanical coupling of agonist-mediated contractions by inhibiting Ca2+ mobilization and Ca2+ sensitivity of myofilaments. Whereas KCl-induced contraction was mediated predominantly by an increase in [Ca2+]i, activation of the GTP-binding protein-coupled receptor modulates uterine artery contractions by changing both cytosolic Ca2+ concentration and the sensitivity of contractile elements to Ca2+. The finding that KCl-mediated contraction and Ca2+ responses were not altered suggests that electromechanical coupling processes may not be affected by chronic hypoxia. Whereas protein kinase C and cGMP and/or cGMP-dependent protein kinase may play a role in chronic hypoxia-mediated attenuation of the agonist-enhanced Ca2+ sensitivity, many other mechanisms remain to be explored. For example, small monomeric GTP-binding proteins, such as Rho A p21 or Ras p21, mediate the agonist-activated pathway for the inhibition of MLCP and enhancement of Ca2+ sensitivity of smooth muscle contractions (10, 17). Modulation of the function of these small GTP-binding proteins could provide a potential target for the effect of chronic hypoxia. It should be borne in mind that the effect of chronic hypoxia on vascular smooth muscle is mediated by multiple modulators, and each modulator may act on more than one site.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by Loma Linda University School of Medicine and in part by National Heart, Lung, and Blood Institute Grant HL-54094, National Institute of Child Health and Human Development Grant HD-31226, and Grant-in-Aid 96007560 from the American Heart Association.
| |
FOOTNOTES |
|---|
Address for reprint requests: L. Zhang, Center for Perinatal Biology, Dept. of Pharmacology, Loma Linda Univ. School of Medicine, Loma Linda, CA 92350.
Received 16 May 1997; accepted in final form 18 August 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akopov, S. E.,
L. Zhang,
and
W. J. Pearce.
Intracranial-extracranial differences in the Ca2+ sensitivity of rabbit arteries.
Proc. Soc. Exp. Biol. Med.
214:
76-82,
1996[Abstract].
2.
Akopov, S. E.,
L. Zhang,
and
W. J. Pearce.
Physiological variations of ovine cerebrovascular calcium sensitivity: role of G proteins.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H2271-H2281,
1997
3.
Akopov, S. E.,
L. Zhang,
and
W. J. Pearce.
Mechanisms of platelet-induced angiospastic disorders: potentiation of calcium sensitivity.
Can. J. Physiol. Pharmacol.
75:
849-852,
1997[Medline].
4.
Berridge, M. J.
Inositol trisphosphate and calcium signaling.
Nature
361:
315-325,
1993[Medline].
5.
Berridge, M. J.
Capacitative Ca2+ entry
sifting through the evidence for CIF.
Biochem. J.
314:
1055-1056,
1996.
6.
Bradley, A. B.,
and
K. G. Morgan.
Alteration in cytoplasmatic calcium sensitivity during porcine coronary artery contractions as detected by aequorin.
J. Physiol. (Lond.)
385:
437-448,
1987
7.
Doyle, W. P.,
and
B. R. Walker.
Attenuation of systemic vasoreactivity in chronically hypoxic rats.
Am. J. Physiol.
260 (Regulatory Integrative Comp. Physiol. 29):
R1114-R1122,
1991
8.
Ehrlich, B. E.,
and
J. Watras.
Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum.
Nature
336:
583-586,
1988[Medline].
9.
Eichinger, M. R.,
T. C. Resta,
D. S. Balderrama,
G. M. Herrera,
L. A. Richardson,
J. M. Resta,
and
B. R. Walker.
Glibenclamide does not reverse attenuated vasoreactivity to acute or chronic hypoxia.
J. Appl. Physiol.
79:
1173-1180,
1995
10.
Gong, M. C.,
K. Iizuka,
G. Nixon,
J. P. Browne,
A. Hall,
J. F. Eccleston,
M. Sugai,
S. Kabayashi,
A. V. Somylo,
and
A. P. Somylo.
Role of guanine nucleotide-binding proteins
ras-family or trimeric proteins or both
in Ca2+ sensitization of smooth muscle.
Proc. Natl. Acad. Sci. USA
93:
1340-1345,
1996
11.
Grynkiewictz, G.,
M. Poenie,
and
R. Y. Tsien.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J. Biol. Chem.
260:
3440-3450,
1985
12.
Hu, X.-Q.,
L. D. Longo,
R. D. Gilbert,
and
L. Zhang.
Effects of long-term, high-altitude hypoxemia on
1-adrenergic receptors in the ovine uterine artery: function and binding studies.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H1001-H1007,
1996
13.
Hu, X.-Q.,
and
L. Zhang.
Chronic hypoxia suppresses pharmacomechanical coupling of the uterine artery in near-term pregnant sheep.
J. Physiol. (Lond.)
499:
551-559,
1997.
14.
Kalsner, S.
Hypoxic relaxation in functionally intact cattle coronary artery segments involves K+ATP channels.
J. Pharmacol. Exp. Ther.
275:
1219-1226,
1995
15.
Kamm, K.,
and
R. W. Grange.
Calcium sensitivity of contraction.
In: Biochemistry of Smooth Muscle Contraction, edited by M. Barany. San Diego, CA: Academic, 1996, p. 355-365.
16.
Karaki, H.
Ca2+ localization and sensitivity in vascular smooth muscle.
Trends Pharmacol. Sci.
10:
320-325,
1989[Medline].
17.
Kimura, K.,
M. Ito,
M. Amano,
K. Chihara,
Y. Fukata,
M. Nakafuku,
B. Yamamori,
J. Feng,
T. Nakano,
K. Okawa,
A. Iwamatsu,
and
K. Kaibuchi.
Regulation of myosin phosphatase by Rho and Rho-associated kinase.
Science
273:
2445-2448,
1996.
18.
Kitazawa, T.,
S. Kobayashi,
K. Horiuti,
A. V. Somylo,
and
A. P. Somylo.
Receptor-coupled, permeabilized smooth muscle. Role of the phosphatidylinositol cascade, G-proteins, and modulation of contractile response to Ca2+.
J. Biol. Chem.
264:
5339-5342,
1989
19.
Kubota, Y.,
M. Nomura,
K. E. Kamm,
M. C. Mumby,
and
J. T. Stull.
GTP
S-dependent regulation of smooth muscle contractile elements.
Am. J. Physiol.
262 (Cell Physiol. 31):
C405-C410,
1992
20.
Le Cras, T. D.,
C. Xue,
A. Rengasmy,
and
R. A. Johns.
Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung.
Am. J. Physiol.
270 (Lung Cell. Mol. Physiol. 14):
L164-L170,
1996
21.
Lincoln, T. M.,
T. L. Cornwell,
P. Komalavilas,
L. A. Macmillan-Crow,
and
N. Boerth.
The nitric oxide-cyclic GMP signaling system.
In: Biochemistry of Smooth Muscle Contraction, edited by M. Barany. San Diego, CA: Academic, 1996, p. 257-268.
22.
Marriott, J. F.,
and
J. M. Marshall.
Differential effects of hypoxia upon contractions evoked by potassium and noradrenaline in rabbit arteries in vitro.
J. Physiol. (Lond.)
422:
1-13,
1990
23.
Marshall, J. M.,
T. Thomas,
and
L. Turner.
A link between adenosine, ATP-sensitive K+ channels, potassium and muscle vasodilatation in the rat in systemic hypoxia.
J. Physiol. (Lond.)
472:
1-9,
1993
24.
Pfitzer, G.,
and
P. J. Boels.
Differential skinning of smooth muscle: a new approach to excitation-contraction coupling.
Blood Vessels
28:
262-267,
1991[Medline].
25.
Quayle, J. M.,
A. D. Bonev,
J. E. Brayden,
and
M. T. Nelson.
Pharmacology of ATP-sensitive K+ currents in smooth muscle cells from rabbit mesenteric artery.
Am. J. Physiol.
269 (Cell Physiol. 38):
C1112-C1118,
1995
26.
Resta, T. C.,
and
B. R. Walker.
Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H888-H896,
1996
27.
Sato, K.,
H. Ozaki,
and
H. Karaki.
Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2.
J. Pharmacol. Exp. Ther.
246:
294-300,
1988
28.
Somlyo, A. P.,
and
A. V. Somlyo.
Signal transduction and regulation in smooth muscle.
Nature
372:
231-236,
1994[Medline].
29.
Ueno, N.,
Y. Zhao,
L. Zhang,
and
L. D. Longo.
High altitude-induced changes in
1-adrenergic receptors and Ins(1,4,5)P3 responses in cerebral arteries.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R669-R674,
1997
30.
Wanstall, J. C.,
I. E. Hughes,
and
S. R. O. Donnell.
Evidence that nitric oxide from the endothelium attenuates inherent tone in isolated pulmonary arteries from rats with hypoxic pulmonary hypertension.
Br. J. Pharmacol.
114:
109-114,
1995[Medline].
31.
Zhang, L. Adaptation of pharmacomechanical coupling of
vascular smooth muscle to chronic hypoxia. Comp.
Biochem. Physiol. In press.
32.
Zhang, L.,
M. E. Bradley,
and
I. L. O. Buxton.
Inositol polyphosphate binding sites and their likely role in calcium regulation in smooth muscle.
Int. J. Biochem. Cell Biol.
27:
1231-1248,
1995[Medline].
33.
Zhang, L.,
M. E. Bradley,
M. Khoyi,
D. P. Westfall,
and
I. L. O. Buxton.
Inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate binding sites in smooth muscle.
Br. J. Pharmacol.
109:
905-912,
1993[Medline].
34.
Zhang, L.,
and
D. C. Dyer.
Characterization of 5-hydroxytryptamine receptors on isolated ovine uterine artery in late pregnancy.
J. Pharmacol. Exp. Ther.
253:
1236-1244,
1990
35.
Zhang, L.,
and
D. C. Dyer.
5-HT2 receptor-stimulated calcium influx in ovine uterine artery in late pregnancy.
Arch. Int. Pharmacodyn. Ther.
310:
46-55,
1991[Medline].
36.
Zhang, L.,
and
X.-Q. Hu.
Serotonin stimulates rapid formation of inositol 1,4,5-trisphosphate in ovine uterine artery: correlation with contractile state.
J. Pharmacol. Exp. Ther.
275:
576-583,
1995
37.
Zhang, L.,
X.-Q. Hu,
and
W. J. Pearce.
Chronic hypoxia suppresses pharmacomechanical coupling in the uterine artery of near-term pregnant sheep: role of cGMP (Abstract).
J. Soc. Gynecol. Investig.
4:
88A,
1997.
38.
Zhou, L.,
Y. Zhao,
R. Nijland,
L. Zhang,
and
L. D. Longo.
Inositol 1,4,5-trisphosphate binding sites in cerebral arteries: changes with development and long-term hypoxia.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R1954-R1959,
1997
This article has been cited by other articles:
![]() |
T. V. Serebrovskaya, E. B. Manukhina, M. L. Smith, H. F. Downey, and R. T. Mallet Intermittent Hypoxia: Cause of or Therapy for Systemic Hypertension? Experimental Biology and Medicine, June 1, 2008; 233(6): 627 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, D. Xiao, L. D. Longo, and L. Zhang Regulation of {alpha}1-adrenoceptor-mediated contractions of uterine arteries by PKC: effect of pregnancy Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2282 - H2289. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, L. D. Longo, and L. Zhang {alpha}1-Adrenoceptor-mediated phosphorylation of MYPT-1 and CPI-17 in the uterine artery: role of ERK/PKC Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2828 - H2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao and L. Zhang Adaptation of uterine artery thick- and thin-filament regulatory pathways to pregnancy Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H142 - H148. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, W. J. Pearce, L. D. Longo, and L. Zhang ERK-mediated uterine artery contraction: role of thick and thin filament regulatory pathways Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1615 - H1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao and L. Zhang Calcium Homeostasis and Contraction of the Uterine Artery: Effect of Pregnancy and Chronic Hypoxia Biol Reprod, April 1, 2004; 70(4): 1171 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, X. Huang, S. Bae, C. A. Ducsay, L. D. Longo, and L. Zhang Cortisol-mediated regulation of uterine artery contractility: effect of chronic hypoxia Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H716 - H722. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, X. Huang, W. J. Pearce, L. D. Longo, and L. Zhang Effect of cortisol on norepinephrine-mediated contractions in ovine uterine arteries Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1142 - H1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Bird, L. Zhang, and R. R. Magness Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R245 - R258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley and B. R. Walker Endothelium-dependent blunting of myogenic responsiveness after chronic hypoxia Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2202 - H2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lindqvist, K. Dreja, K. Sward, and P. Hellstrand Effects of oxygen tension on energetics of cultured vascular smooth muscle Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H110 - H117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, J. S. Naik, and B. R. Walker 48-h Hypoxic exposure results in endothelium-dependent systemic vascular smooth muscle cell hyperpolarization Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R79 - R85. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gonzales and B. R. Walker Role of CO in attenuated vasoconstrictor reactivity of mesenteric resistance arteries after chronic hypoxia Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H30 - H37. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao and L. Zhang ERK MAP kinases regulate smooth muscle contraction in ovine uterine artery: effect of pregnancy Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H292 - H300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, W. J. Pearce, and L. Zhang Pregnancy enhances endothelium-dependent relaxation of ovine uterine artery: role of NO and intracellular Ca2+ Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H183 - H190. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Jernigan, T. L. O'Donaughy, and B. R. Walker Correlation of HO-1 expression with onset and reversal of hypoxia-induced vasoconstrictor hyporeactivity Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H298 - H307. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, I. M. Bird, R. R. Magness, L. D. Longo, and L. Zhang Upregulation of eNOS in pregnant ovine uterine arteries by chronic hypoxia Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H812 - H820. [Abstract] [Full Text] [PDF] |
||||